beyfortus
astrazeneca ab - nirsevimab - immunrendszer sera, immunglobulinok, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
betaloc zok 100 mg retard tabletta
astrazeneca kft. - metoprolol -
naropin 20 mg/10 ml (2 mg/ml) injekció
astrazeneca kft. - ropivacaine -
naropin 75 mg/10 ml (7,5 mg/ml) injekció
astrazeneca kft. - ropivacaine -
naropin 200 mg/100 ml (2,0 mg/ml) infúzió
astrazeneca kft. - ropivacaine -
naropin 200 mg/20 ml (10 mg/ml) injekció
astrazeneca kft. - ropivacaine -
naropin 400 mg/200 ml (2,0 mg/ml) infúzió
astrazeneca kft. - ropivacaine -
betaloc zok 200 mg retard tabletta
astrazeneca kft. - metoprolol -
atacand plus 16 mg/12,5 mg tabletta
astrazeneca kft. - candesartan; hydrochlorothiazide -
crestor 40 mg filmtabletta
astrazeneca kft. - rosuvastatin -